Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DateTimeSourceHeadlineSymbolCompany
04/30/20243:15PMGlobeNewswire Inc.BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024NASDAQ:BRTXBioRestorative Therapies Inc
04/30/20246:30AMGlobeNewswire Inc.BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics TechnologyNASDAQ:BRTXBioRestorative Therapies Inc
04/16/20249:25AMAllPennyStocks.comBiotech Catches Major Premarket Bid Following FDA ClearanceNASDAQ:BRTXBioRestorative Therapies Inc
04/16/20246:45AMGlobeNewswire Inc.BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentNASDAQ:BRTXBioRestorative Therapies Inc
04/08/20246:45AMGlobeNewswire Inc.BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
04/03/20243:38PMGlobeNewswire Inc.BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsNASDAQ:BRTXBioRestorative Therapies Inc
04/01/20246:45AMGlobeNewswire Inc.BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KNASDAQ:BRTXBioRestorative Therapies Inc
03/11/20243:15PMGlobeNewswire Inc.BioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
03/06/20243:34PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:43PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:40PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20243:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/14/202412:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/12/20248:26AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/09/20247:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/08/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/06/20247:05AMGlobeNewswire Inc.BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketNASDAQ:BRTXBioRestorative Therapies Inc
02/05/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/05/20246:30AMGlobeNewswire Inc.BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
02/01/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/01/20246:30AMGlobeNewswire Inc.BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual MeetingNASDAQ:BRTXBioRestorative Therapies Inc
12/12/20238:15AMGlobeNewswire Inc.BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramNASDAQ:BRTXBioRestorative Therapies Inc
12/05/20233:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
12/01/20234:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX